HUMANA INC
HUMAPI behind this page
HUM Q2 2025 request
Playground key active
/api/financials?ticker=HUM&year=2025&quarter=2
Pick an endpoint and run the request.
Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Premiums Earned Net | 30,716 | 28,142 | +9.1% |
Show Product Lines breakouts |
|||
| Product | 30,716 | 28,142 | +9.1% |
| Product · Insurance | 30,716 | 28,142 | +9.1% |
| Revenue From Contract With Customer Including Assessed Tax | 1,400 | 1,100 | +27.3% |
Show Product Lines breakouts |
|||
| Service | 1,400 | 1,100 | +27.3% |
| Service · CenterWell | 1,194 | 886 | +34.8% |
| Service · Insurance | 206 | 214 | -3.7% |
| Investment Income Interest And Dividend | 272 | 298 | -8.7% |
| Revenue | 32,388 | 29,540 | +9.6% |
Show Product Lines breakouts |
|||
| External Revenues | 32,116 | 29,242 | +9.8% |
| External Revenues · CenterWell | 1,194 | 886 | +34.8% |
| External Revenues · Insurance | 30,922 | 28,356 | +9.0% |
Show Business Segments breakouts |
|||
| CenterWell · Corporate And Eliminations [Member] | 4,343 | 4,061 | +6.9% |
| CenterWell · Operating Segments | 5,537 | 4,947 | +11.9% |
| Insurance · Corporate And Eliminations [Member] | 1 | 1 | 0.0% |
| Insurance · Operating Segments | 31,094 | 28,525 | +9.0% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -4,243 | -3,932 | -7.9% |
| Intersegment Elimination | -4,344 | -4,062 | -6.9% |
| Policyholder Benefits And Claims Incurred Net | 27,565 | 25,039 | +10.1% |
Show Business Segments breakouts |
|||
| Insurance · Operating Segments | 27,621 | 25,182 | +9.7% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -56 | -143 | +60.8% |
| Selling, General & Administrative | 3,547 | 3,148 | +12.7% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 5,133 | 4,553 | +12.7% |
| Insurance · Operating Segments | 2,558 | 2,395 | +6.8% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -4,144 | -3,800 | -9.1% |
| Depreciation And Amortization | 178 | 212 | -16.0% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 60 | 56 | +7.1% |
| Insurance · Operating Segments | 149 | 185 | -19.5% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -31 | -29 | -6.9% |
| Benefits Losses And Expenses | 31,290 | 28,399 | +10.2% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 5,193 | 4,609 | +12.7% |
| Insurance · Operating Segments | 30,328 | 27,762 | +9.2% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -4,231 | -3,972 | -6.5% |
| Operating Income | 1,098 | 1,141 | -3.8% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 344 | 338 | +1.8% |
| Insurance · Operating Segments | 766 | 763 | +0.4% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -12 | 40 | -130.0% |
| Interest Expense | 157 | 168 | -6.5% |
| Other Non-Operating Income (Expense) | 200 | 55 | +263.6% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 741 | 918 | -19.3% |
| Income Tax Expense (Benefit) | 179 | 223 | -19.7% |
| Income Loss From Equity Method Investments | -19 | -17 | -11.8% |
| Net Income | 543 | 678 | -19.9% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -2 | -1 | -100.0% |
| Parent | 545 | 679 | -19.7% |
| Retained Earnings | 545 | 679 | -19.7% |
| Net Income Loss Attributable To Noncontrolling Interest | 2 | 1 | +100.0% |
| Net Income | 545 | 679 | -19.7% |
| EPS (Basic) | 4.52 | 5.63 | -19.7% |
| EPS (Diluted) | 4.51 | 5.62 | -19.8% |
| Comprehensive Income | 630 | 643 | -2.0% |
| Other Comprehensive Income | 85 | -36 | +336.1% |
| Wtd Avg Shares (Basic) | 120,539 | 120,445 | +0.1% |
| Wtd Avg Shares (Diluted) | 120,745 | 120,665 | +0.1% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 4,040 | 5,501 | -26.6% |
| Short-Term Investments | 17,668 | 17,424 | +1.4% |
| Receivables Net Current | 4,504 | 4,090 | +10.1% |
| Other Assets Current | 7,403 | — | — |
| Total Current Assets | 33,615 | 32,858 | +2.3% |
| Accounts Receivable (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Service | 373 | 395 | -5.6% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,356 | 2,821 | -16.5% |
| Available For Sale Securities Debt Securities Noncurrent | 431 | 388 | +11.1% |
| Goodwill | 9,633 | — | — |
Show Business Segments breakouts |
|||
| CenterWell | 6,970 | — | — |
| Insurance | 2,663 | — | — |
| Other Non-Current Assets | 3,686 | — | — |
| Total Assets | 50,357 | 50,093 | +0.5% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Contractual Rights | 3 | — | — |
| Customer Contracts | 183 | — | — |
| Noncompetes and other | 30 | — | — |
| Trade Names | 16 | — | — |
| Other Assets | |||
| Equity Method Investments | 636 | 736 | -13.6% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 11,060 | 11,446 | -3.4% |
| Accounts Payable And Accrued Liabilities Current | 5,587 | — | — |
| Book Overdraft Liability | 298 | 355 | -16.1% |
| Deferred Revenue (Current) | 274 | 313 | -12.5% |
| Total Current Liabilities | 17,219 | 19,790 | -13.0% |
| Non-Current Liabilities | |||
| Long-Term Debt | 12,586 | — | — |
Show Debt Instrument breakouts |
|||
| $1,000 million, 5.750% due April 15, 2054 · Senior Notes | 994 | — | — |
| $1,500 million, 5.375% due April 15, 2031 · Senior Notes | 1,492 | — | — |
| $250 million, 8.150% due June 15, 2038 · Senior Notes | 260 | — | — |
| $400 million, 4.625% due December 1, 2042 · Senior Notes | 377 | — | — |
| $400 million, 4.800% due March 15, 2047 · Senior Notes | 398 | — | — |
| $500 million, 3.950% due August 15, 2049 · Senior Notes | 519 | — | — |
| $500 million, 5.750% due December 1, 2028 · Senior Notes | 496 | — | — |
| $500 million, 5.750% due March 1, 2028 · Senior Notes | 490 | — | — |
| $500 million, 6.000% due May 1, 2055 · Senior Notes | 489 | — | — |
| $500 million, 3.125% due August 15, 2029 · Senior Notes | 433 | — | — |
| $500 million, 4.875% due April 1, 2030 · Senior Notes | 497 | — | — |
| $600 million, 3.950% due March 15, 2027 · Senior Notes | 465 | — | — |
| $750 million, 3.700% due March 23, 2029 · Senior Notes | 586 | — | — |
| $750 million, 5.500% due March 15, 2053 · Senior Notes | 728 | — | — |
| $750 million, 5.550% due May 1, 2035 · Senior Notes | 747 | — | — |
| $750 million, 5.875% due March 1, 2033 · Senior Notes | 750 | — | — |
| $750 million, 1.350% due February 3, 2027 · Senior Notes | 563 | — | — |
| $750 million, 2.150% due February 3, 2032 · Senior Notes | 745 | — | — |
| $750 million, 4.950% due October 1, 2044 · Senior Notes | 725 | — | — |
| $850 million, 5.950% due March 15, 2034 · Senior Notes | 832 | — | — |
Show Long-Term Debt Type breakouts |
|||
| Senior Notes | 12,586 | — | — |
| Other Non-Current Liabilities | 2,257 | — | — |
| Total Liabilities | 32,062 | 33,365 | -3.9% |
| Stockholders' Equity | |||
| Common Stock | 33 | 33 | 0.0% |
| Additional Paid In Capital Common Stock | 3,557 | 3,420 | +4.0% |
| Retained Earnings | 29,891 | 28,745 | +4.0% |
| Accumulated Other Comprehensive Income | -783 | -1,122 | +30.2% |
| Treasury Stock Common Value | -14,464 | -14,405 | -0.4% |
| Total Stockholders' Equity | 18,234 | 16,671 | +9.4% |
| Minority Interest | 61 | 57 | +7.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 18,295 | 16,728 | +9.4% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -783 | -1,122 | +30.2% |
| Additional Paid In Capital | 3,557 | 3,420 | +4.0% |
| Common Stock | 33 | 33 | 0.0% |
| Noncontrolling Interest | 61 | 57 | +7.0% |
| Parent | 18,234 | 16,671 | +9.4% |
| Retained Earnings | 29,891 | 28,745 | +4.0% |
| Treasury Stock Common | -14,464 | -14,405 | -0.4% |
| Total Liabilities & Equity | 50,357 | 50,093 | +0.5% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Debt And Equity Securities Gain Loss | -13 | — | — |
| Stock-Based Compensation | 110 | 100 | +10.0% |
| Depreciation | 396 | 454 | -12.8% |
| Adjustment For Amortization | 30 | 31 | -3.2% |
| Tangible Asset Impairment Charges | 14 | 87 | -83.9% |
| Impairment Of Intangible Assets Indefinitelived Excluding Goodwill | 32 | — | — |
| Increase Decrease In Receivables | -1,800 | -2,055 | +12.4% |
| Increase Decrease In Other Operating Assets | -658 | 592 | -211.1% |
| Increase Decrease In Health Care Insurance Liabilities | 620 | 1,205 | -48.5% |
| Increase Decrease In Other Operating Liabilities | 1,010 | -327 | +408.9% |
| Change in Deferred Revenue | 14 | 47 | -70.2% |
| Net Cash from Operations | 1,602 | 1,636 | -2.1% |
| Investing Activities | |||
| Payments To Acquire Businesses Net Of Cash Acquired | 1 | 17 | -94.1% |
| Capital Expenditures | -209 | -291 | +28.2% |
| Purchases of Investments | -1,941 | -2,883 | +32.7% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 1,617 | 1,355 | +19.3% |
| Proceeds From Sale Of Available For Sale Securities Debt | 1,243 | 499 | +149.1% |
| Increase Decrease In Collateral Held Under Securities Lending | -48 | -79 | +39.2% |
| Net Cash from Investing | 661 | -1,416 | +146.7% |
| Fair Value Of Assets Acquired | 2 | 26 | -92.3% |
| Liabilities Assumed1 | -1 | -9 | +88.9% |
| Financing Activities | |||
| Payments For Proceeds From Contract Deposits | -579 | 285 | -303.2% |
| Proceeds From Issuance Of Senior Long Term Debt | 1,481 | 2,232 | -33.6% |
| Repayments Of Senior Debt | -771 | -34 | -2167.6% |
| Proceeds From Repayments Of Commercial Paper | -5 | -895 | +99.4% |
| Debt Issuance Costs | -5 | -7 | +28.6% |
| Increase Decrease In Book Overdrafts | -105 | 2 | -5350.0% |
| Share Repurchases | -109 | -766 | +85.8% |
| Payments Of Dividends | -214 | -216 | +0.9% |
| Increase Decrease In Securities Lending Payable | 48 | 79 | -39.2% |
| Increase Decrease In Rebate Factor Payable | -123 | — | — |
| Proceeds From Payments For Other Financing Activities | -62 | -93 | +33.3% |
| Net Cash from Financing | -444 | 587 | -175.6% |
| Supplemental | |||
| Interest Paid | 293 | 250 | +17.2% |
| Income Taxes Paid | 29 | 362 | -92.0% |
| Other Cash Flow | |||
| Net Change in Cash | 1,819 | 807 | +125.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4,040 | 5,501 | -26.6% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.